Aleksandra Gradek

Aleksandra Gradek

Auto-generated profile, based on publicly available information

Aleksandra Gradek

University Clinical Center in Gdańsk, ul. Dębinki 7, 80-952 Gdańsk, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
PMPatryk Macuk
Patryk Macuk
ALAnna Leśniewska
Anna Leśniewska
JTJulia Anita Tarnowska
Julia Anita Tarnowska
FSFilip Szydzik
Filip Szydzik
BŻBartosz Żegleń
Bartosz Żegleń
AGAleksandra Gradek
Aleksandra Gradek
Objectives: Syncope in athletes presents a complex diagnostic challenge requiring systematic evaluation to differentiate benign neurally-mediated causes from potentially life-threatening cardiac conditions. Unrecognized cardiovascular disease in athletes can lead to sudden cardiac death, making accurate risk stratification essential for athlete safety and appropriate return-to-play decisions. We aim to provide a comprehensive synthesis of current evidence regarding the indications, protocols, diagnostic yield, and limitations of exercise stress testing in athletes presenting with syncope. Methods: We conducted a narrative literature review of PubMed databases from 2004-2025, focusing on studies involving athletic populations and recent consensus statements from major cardiovascular and sports medicine organizations. Evidence was synthesized from observational studies, clinical guidelines, and expert consensus documents. Key findings: Exercise stress testing is strongly recommended for all athletes with exertional syncope, with sport-specific, maximal-effort protocols yielding arrhythmic or ischemic findings in 15-25% of cases. Negative predictive values approach 95% when proper protocols are employed, significantly reducing the probability of exercise-induced life-threatening events, though residual risk remains. Current evidence supports individualized testing protocols rather than generic clinical protocols designed for ischemia detection. Integration with comprehensive clinical assessment, ECG, echocardiography, and risk factor evaluation optimizes diagnostic accuracy and clinical decision-making. Conclusions: Sport-specific, effortful exercise stress testing serves as a pivotal diagnostic tool and safety gatekeeper in athletic syncope evaluation. When integrated within systematic algorithms it enables accurate risk stratification, specialist referral, and evidence-based return-to-play decisions. Future research should focus on protocol validation, long-term outcome studies, and integration of emerging technologies for further enhancement of diagnostic precision.

22 August 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
BŻBartosz Żegleń
Bartosz Żegleń
PMPatryk Macuk
Patryk Macuk
ALAnna Leśniewska
Anna Leśniewska
JTJulia Anita Tarnowska
Julia Anita Tarnowska
FSFilip Szydzik
Filip Szydzik
AGAleksandra Gradek
Aleksandra Gradek
Objective: This review aims to synthesize current evidence on the injury epidemiology of kitesurfing, focusing on common trauma patterns, underlying risk factors, and the effectiveness of safety strategies. Methods: A systematic literature search was conducted in PubMed and SPORTDiscus for articles published between 2000 and 2024. Studies were included if they reported original quantitative data on kitesurfing-related injuries, including incidence, anatomical distribution, severity, or safety practices. A narrative synthesis was applied due to methodological heterogeneity. Results: Injury incidence rates ranged from 4.3 to 10.5 per 1, 000 hours of kitesurfing exposure. The most frequently injured areas were the lower extremities, particularly the foot, ankle, and knee. Common injury types included abrasions, sprains, and soft-tissue trauma, with serious injuries such as spinal fractures and head trauma occurring less frequently but with notable severity. Experience level was inversely correlated with injury risk, while environmental factors—such as wind instability and shallow water—significantly contributed to accidents. Although quick-release harness systems are now widely adopted (97%), their real-time use during injury events remains low (7.3%). Helmet (4%) and impact vest (19.5%) usage remains limited despite recommendations. Conclusion: Kitesurfing presents a distinct injury profile influenced by biomechanical demands, environmental variables, and user behavior. While most injuries are mild and permit rapid return to sport, severe cases still occur, underscoring the need for improved safety education, structured training, and increased protective gear compliance. Future research should emphasize standardized reporting and long-term outcome tracking to better inform injury prevention strategies.

4 August 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
DNDominika Nowak
Dominika Nowak
AZAdam Zarzycki
Adam Zarzycki
PDPatrycja Długosz
Patrycja Długosz
MPMagdalena Próchnicka
Magdalena Próchnicka
AGAleksandra Gradek
Aleksandra Gradek
JNJan Noskowicz
Jan Noskowicz
Introduction: Inherited retinal diseases (IRDs) are a group of disorders that lead to progressive vision loss, for which no effective treatments have previously been available. Advances in molecular biology have enabled the development of gene therapies and innovative strategies such as optogenetics, offering hope for improvement or restoration of visual function. Aim: The aim of this work is to present the current state of knowledge regarding gene therapies used in IRDs, with particular emphasis on their mechanisms of action, possibilities for personalization, integration with other methods, and the potential of optogenetics as an alternative in advanced stages of the disease. Methods: A literature review was performed using PubMed, Google Scholar, Scopus, and Web of Science. Thirty-nine English publications relevant to inherited retinal diseases and gene therapies were selected. Studies covered mechanisms, efficacy, safety, and diagnostic advances. Irrelevant or methodologically weak papers were excluded. Results: Therapies based on AAV vectors, CRISPR/Cas9 techniques, prime editing, and antisense oligonucleotides demonstrate effectiveness depending on the type of mutation and disease stage. Optogenetics enables the restoration of light sensitivity regardless of the mutation, even in the absence of photoreceptors. Combining gene therapy with other methods, such as stem cells or neuroprotection, enhances therapeutic potential. Conclusions: Gene and optogenetic therapies are transforming the treatment approach for IRDs. Selecting strategies based on the molecular background and disease stage enables a personalized approach. Technical and regulatory challenges remain, but development trends indicate a real possibility of effective treatment for many forms of IRDs.

27 August 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ANAleksandra Nowińska
Aleksandra Nowińska
MGMonika Grudzień
Monika Grudzień
AGAnna Gryc
Anna Gryc
JLJakub Lipiec
Jakub Lipiec
MNMarcin Narloch
Marcin Narloch
MSMarta Steuden
Marta Steuden
Anorexia nervosa (AN) is a severe and debilitating disorder with the highest standardized mortality rate among all mental health conditions. It is associated with cognitive impairments and difficulties in emotional regulation. Individuals with AN often exhibit a reduced ability to recognize emotions (Emotion Recognition Ability – ERA), particularly when it comes to negative emotions. The efficiency of emotion recognition has been found to correlate with Body Mass Index (BMI) and the duration of the illness, which may suggest a decline in socio-emotional functioning and neurobiological changes caused by prolonged starvation. Impaired emotion recognition is linked to poorer treatment outcomes, making it crucial to focus on enhancing this skill during AN therapy. Since ERA plays a fundamental role in nonverbal communication – and, by extension, in social interactions – further research in this area is warranted. Available training programs aimed at improving emotion recognition abilities have the potential to significantly enhance communication between patients and healthcare providers as well as close relatives, thereby positively influencing the therapeutic process.

22 July 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MSMarcin Sawczuk
Marcin Sawczuk
AGAleksandra Gradek
Aleksandra Gradek
DNDominika Nowak
Dominika Nowak
AZAdam Zarzycki
Adam Zarzycki
JTJulia Anita Tarnowska
Julia Anita Tarnowska
PMPatryk Macuk
Patryk Macuk
Introduction and Aim: The advancement of immunosuppressive therapy has significantly increased organ transplantations. Among immunosuppressive agents, basiliximab and anti-thymocyte globulin (ATG) are key in induction therapy. However, clear guidelines on when to use basiliximab alone, ATG alone, or their combination are lacking, posing clinical challenges. This study aims to review recent data on basiliximab and ATG use in induction therapy post-transplant. Materials and Methods: A literature review was conducted using PubMed with keywords “basiliximab”, “ATG” and “immunosupression" including articles published up to September 2024, focusing on studies from the last two years. The review targeted information on their application in induction immunosuppression after vascularized organ transplantation, effects relative to organ type, and drug combinations. Results: Basiliximab and ATG differ in efficacy and side effects. ATG is more effective in reducing acute rejection, especially in high-risk patients, but carries higher infection and hematologic risks. Basiliximab has a better safety profile, suitable for elderly or low-risk patients. Treatment should be individualized by age, immunological risk, and infection susceptibility. Steroid continuation after basiliximab induction improves outcomes, a benefit not clearly seen with ATG. Conclusion: Induction therapy is advised for high-risk patients and certain transplants, mainly using ATG, Grafalon, or basiliximab. ATG may be a safe, effective alternative to basiliximab, which is preferred in older or comorbid patients. Limited data support ATG use in other transplants like pediatric heart transplants. Further multicenter trials and personalized therapy are needed.

16 July 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KKKatarzyna Kozon
Katarzyna Kozon
KKKatarzyna Krupa
Katarzyna Krupa
PFPatrycja Fiertek
Patrycja Fiertek
Adrianna BrzozowskaAdrianna Brzozowska
Adrianna Brzozowska
KNKarolina Niewczas
Karolina Niewczas
MSMarcin Sawczuk
Marcin Sawczuk
Dravet syndrome is a severe, early childhood epileptic encephalopathy, most often associated with a mutation in the SCN1a gene characterized by drug resistance and high neurological burden. For many years treatment was limited to non-specific antiepileptic drugs, but recently new, targeted therapies have appeared, which have significantly improved the prognosis of patients. Stiripentol, modulating GABAergic transmission, has been approved as an adjuctive treatment in the treatment of Dravet syndrome, showing a significant reduction in the frequency of seizures in combination with clobazam and valproic acid. In turn, fenfluramine, acting on serotonin receptors, among others, has proven also effective. Both drugs have been approved by the FDA and EMA, constitiuting a breakthrough in the treatment of Dravet syndrome Their introduction has significantly improved the quality of life of patients and opened up new perspectives in the treatment of developmental epilepsies.